Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - ACCOUNTS PAYABLE
Accounts Payable LRMR - Larimar Therapeutics, Inc.
1.28 M
LAST VALUE
-12.09%
2 YEAR CAGR
7.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR